for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Medifast Inc

MED

Latest Trade

164.90USD

Change

0.49(+0.30%)

Volume

72,550

Today's Range

162.50

 - 

166.43

52 Week Range

49.03

 - 

184.29

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
164.41
Open
163.90
Volume
72,550
3M AVG Volume
5.61
Today's High
166.43
Today's Low
162.50
52 Week High
184.29
52 Week Low
49.03
Shares Out (MIL)
11.77
Market Cap (MIL)
1,934.37
Forward P/E
18.73
Dividend (Yield %)
2.75

Next Event

Q3 2020 Medifast Inc Earnings Release

Latest Developments

More

Medifast Q2 Adjusted Non-GAAP Earnings Per Share $1.96

Medifast Says Engaged Capital Reported Stake Of 5.8% In Medifast

Medifast Q1 Earnings Per Share $1.56

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Medifast Inc

Medifast, Inc. produces, distributes and sells weight loss, weight management, and healthy living products, and other consumable health and nutritional products. The Company’s product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products, and vitamins. Its business units include Optavia, Medifast Direct, Franchise Medifast Weight Control Centers (MWCC) and Medifast Wholesale. Optavia is a personal coaching division of the Company that consists of Optavia Coaches, who provides coaching and support to clients utilizing the Optavia platform. Medifast Direct is its direct-to-consumer business unit that allows customers to order Medifast products directly through its Website or its in-house call center. The MWCC business unit sells product through franchise and reseller locations, which offers structured programs and a team of professionals to help customers achieve weight-loss and weight-management success at center locations.

Industry

Biotechnology & Drugs

Contact Info

11445 Cronhill Dr

OWINGS MILLS, MD

21117-2270

United States

+1.732.7640619

https://www.medifast1.com

Executive Leadership

Michael Charles MacDonald

Non-Executive Chairman of the Board

Daniel R. Chard

Chief Executive Officer, Director

James P. Maloney

Chief Financial Officer

Jason L. Groves

Executive Vice President, General Counsel, Corporate Secretary

Claudia Greninger

Executive Vice President - Human Resources

Key Stats

2.60 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

0.3K

2018

0.5K

2019

0.7K

2020(E)

0.9K
EPS (USD)

2017

2.290

2018

4.620

2019

6.430

2020(E)

8.780
Price To Earnings (TTM)
25.69
Price To Sales (TTM)
2.55
Price To Book (MRQ)
16.56
Price To Cash Flow (TTM)
23.55
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
58.16
Return on Equity (TTM)
34.27

Latest News

Latest News

BRIEF-Medifast Inc Q1 Earnings Per Share $1.01

* MEDIFAST, INC. ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Medifast Q4 Earnings Per Share $0.60

* MEDIFAST, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Medifast Announces Global Expansion With Its Lifestyle Brand Optavia

* MEDIFAST ANNOUNCES GLOBAL EXPANSION WITH ITS LIFESTYLE BRAND, OPTAVIA®

BRIEF-Medifast Announces 50 Percent Increase In Quarterly Dividend

* MEDIFAST, INC. ANNOUNCES 50 PERCENT INCREASE IN QUARTERLY DIVIDEND

BRIEF-Medifast posts Q3 earnings per share $0.55

* Cash, cash equivalents, investment securities rose $18.9 million to $95.7 million as of Sept. 30,2017 compared to $76.8 million at Dec. 31,2016 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up